NEW YORK (GenomeWeb News) – Biotechnology company Antigen Discovery said today it has received a three-year, $2.5 million award from the National Institutes of Health to use its proteome microarray technology to develop companion diagnostics for Sanaria's malaria products in human trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.